Giuseppe Curigliano
Giuseppe Curigliano is a prominent oncologist and the elected president of the European Society of Medical Oncology (ESMO). He serves as the Director of the New Drug Development Division at the European Institute of Oncology in Milan. Curigliano is well-respected in the field for his work in cancer research and his advocacy for streamlining clinical trial approvals in Italy, aiming to enhance the country's competitiveness in global oncology research.
Not in the pool (under ¢1).
Recent news mentions
Giuseppe Curigliano is the director of the Division of New Drug Development at the European Institute of Oncology.
Primi appuntamenti con l'oncologo: cosa fare? Cinque consigli pratici per chi ha un tumore in stadio iniziale
Italy· 2025-09-02Giuseppe Curigliano is the director of the Division of new drugs for innovative therapies at the European Institute of Oncology in Milan.
Tumori: i test che servono davvero, a che cosa e a chiItaly· 2025-06-01
Giuseppe Curigliano is an oncologist who has treated metastatic patients and is currently the Director of the Division of New Drug Development at the European Institute of Oncology in Milan.
Giuseppe Curigliano: «La Fallaci fu mia paziente, mi disse: vai contro i primari. Farei il professore di filologia»Italy· 2025-05-14
Giuseppe Curigliano is the elected president of the European Society of Medical Oncology and emphasizes the importance of reducing bureaucratic obstacles in cancer research.
Ricerca sul cancro: l'Italia fra i cinque migliori Paesi al mondo, ma la burocrazia è un ostacolo che minaccia medici e pazientiItaly· 2025-03-19